Phyre 2 Results for O00459

Phyre Home | Retrieve Phyre Job Id

Email | l.a.kelley@imperial.ac.uk
Description | O00459
Date | Fri May 25 09:44:30 BST 2012
Unique Job ID | 0ae9a79684a9af6d

Summary |

Top model
Image coloured by rainbow N → C terminus
| Close Jmol

Model (left) based on template c2oq1A_
Top template information
PDB header:transferase Chain: A: PDB Molecule:tyrosine-protein kinase zap-70; PDBTitle: tandem sh2 domains of zap-70 with 19-mer zeta1 peptide
Confidence and coverage
Confidence: | 100.0% | Coverage: | 34%
247 residues ( 34% of your sequence) have been modelled with 100.0% confidence by the single highest scoring template.
Additional confident templates have been detected (see Domain analysis) which cover other regions of your sequence.
659 residues ( 91%) could be modelled at >90% confidence using multiple-templates.
You may wish to try resubmitting your sequence in "intensive" mode to model more of your sequence.
3D viewing
Interactive 3D view in Jmol

Sequence analysis |

Secondary structure and disorder prediction |

|  | 1 | . | . | . | . | . | . | . | . | 10 | . | . | . | . | . | . | . | . | . | 20 | . | . | . | . | . | . | . | . | . | 30 | . | . | . | . | . | . | . | . | . | 40 | . | . | . | . | . | . | . | . | . | 50 | . | . | . | . | . | . | . | . | . | 60
Sequence |  | M | A | G | P | E | G | F | Q | Y | R | A | L | Y | P | F | R | R | E | R | P | E | D | L | E | L | L | P | G | D | V | L | V | V | S | R | A | A | L | Q | A | L | G | V | A | E | G | G | E | R | C | P | Q | S | V | G | W | M | P | G | L
Secondary structure |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SS confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder |  | ? | ? | ? | ? | ? | ? | ? |  |  |  |  |  |  |  |  |  | ? |  |  | ? | ? |  | ? |  |  |  |  | ? |  |  |  |  |  |  | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? |  |  |  |  |
Disorder confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | . | . | . | . | . | . | . | . | . | 70 | . | . | . | . | . | . | . | . | . | 80 | . | . | . | . | . | . | . | . | . | 90 | . | . | . | . | . | . | . | . | . | 100 | . | . | . | . | . | . | . | . | . | 110 | . | . | . | . | . | . | . | . | . | 120
Sequence |  | N | E | R | T | R | Q | R | G | D | F | P | G | T | Y | V | E | F | L | G | P | V | A | L | A | R | P | G | P | R | P | R | G | P | R | P | L | P | A | R | P | R | D | G | A | P | E | P | G | L | T | L | P | D | L | P | E | Q | F | S | P
Secondary structure |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SS confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder |  |  |  | ? | ? | ? | ? | ? |  | ? |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? |  |  |  |  |  |  | ? |  | ? | ? | ? | ?
Disorder confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | . | . | . | . | . | . | . | . | . | 130 | . | . | . | . | . | . | . | . | . | 140 | . | . | . | . | . | . | . | . | . | 150 | . | . | . | . | . | . | . | . | . | 160 | . | . | . | . | . | . | . | . | . | 170 | . | . | . | . | . | . | . | . | . | 180
Sequence |  | P | D | V | A | P | P | L | L | V | K | L | V | E | A | I | E | R | T | G | L | D | S | E | S | H | Y | R | P | E | L | P | A | P | R | T | D | W | S | L | S | D | V | D | Q | W | D | T | A | A | L | A | D | G | I | K | S | F | L | L | A
Secondary structure |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SS confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ? | ? | ? |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | . | . | . | . | . | . | . | . | . | 190 | . | . | . | . | . | . | . | . | . | 200 | . | . | . | . | . | . | . | . | . | 210 | . | . | . | . | . | . | . | . | . | 220 | . | . | . | . | . | . | . | . | . | 230 | . | . | . | . | . | . | . | . | . | 240
Sequence |  | L | P | A | P | L | V | T | P | E | A | S | A | E | A | R | R | A | L | R | E | A | A | G | P | V | G | P | A | L | E | P | P | T | L | P | L | H | R | A | L | T | L | R | F | L | L | Q | H | L | G | R | V | A | S | R | A | P | A | L | G
Secondary structure |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SS confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ? |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ? | ? | ? | ? | ? | ?
Disorder confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | . | . | . | . | . | . | . | . | . | 250 | . | . | . | . | . | . | . | . | . | 260 | . | . | . | . | . | . | . | . | . | 270 | . | . | . | . | . | . | . | . | . | 280 | . | . | . | . | . | . | . | . | . | 290 | . | . | . | . | . | . | . | . | . | 300
Sequence |  | P | A | V | R | A | L | G | A | T | F | G | P | L | L | L | R | A | P | P | P | P | S | S | P | P | P | G | G | A | P | D | G | S | E | P | S | P | D | F | P | A | L | L | V | E | K | L | L | Q | E | H | L | E | E | Q | E | V | A | P | P
Secondary structure |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SS confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder |  | ? | ? | ? |  |  | ? | ? | ? | ? | ? |  |  | ? |  |  |  |  | ? | ? | ? | ? | ? |  |  |  |  |  |  |  | ? |  |  | ? |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | . | . | . | . | . | . | . | . | . | 310 | . | . | . | . | . | . | . | . | . | 320 | . | . | . | . | . | . | . | . | . | 330 | . | . | . | . | . | . | . | . | . | 340 | . | . | . | . | . | . | . | . | . | 350 | . | . | . | . | . | . | . | . | . | 360
Sequence |  | A | L | P | P | K | P | P | K | A | K | P | A | S | T | V | L | A | N | G | G | S | P | P | S | L | Q | D | A | E | W | Y | W | G | D | I | S | R | E | E | V | N | E | K | L | R | D | T | P | D | G | T | F | L | V | R | D | A | S | S | K
Secondary structure |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SS confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder |  | ? | ? | ? | ? | ? | ? |  | ? | ? |  |  | ? | ? |  |  | ? | ? | ? | ? | ? |  | ? | ? |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ? | ? | ? | ? | ? |  |  |  |  |  |  |  |  |  |  |
Disorder confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | . | . | . | . | . | . | . | . | . | 370 | . | . | . | . | . | . | . | . | . | 380 | . | . | . | . | . | . | . | . | . | 390 | . | . | . | . | . | . | . | . | . | 400 | . | . | . | . | . | . | . | . | . | 410 | . | . | . | . | . | . | . | . | . | 420
Sequence |  | I | Q | G | E | Y | T | L | T | L | R | K | G | G | N | N | K | L | I | K | V | F | H | R | D | G | H | Y | G | F | S | E | P | L | T | F | C | S | V | V | D | L | I | N | H | Y | R | H | E | S | L | A | Q | Y | N | A | K | L | D | T | R
Secondary structure |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SS confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ? | ? | ? | ? | ? |  |  |  |  |  |  |
Disorder confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | . | . | . | . | . | . | . | . | . | 430 | . | . | . | . | . | . | . | . | . | 440 | . | . | . | . | . | . | . | . | . | 450 | . | . | . | . | . | . | . | . | . | 460 | . | . | . | . | . | . | . | . | . | 470 | . | . | . | . | . | . | . | . | . | 480
Sequence |  | L | L | Y | P | V | S | K | Y | Q | Q | D | Q | I | V | K | E | D | S | V | E | A | V | G | A | Q | L | K | V | Y | H | Q | Q | Y | Q | D | K | S | R | E | Y | D | Q | L | Y | E | E | Y | T | R | T | S | Q | E | L | Q | M | K | R | T | A
Secondary structure |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SS confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder |  |  |  |  |  |  |  |  |  | ? | ? | ? | ? | ? |  |  |  |  | ? |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ? | ? | ? | ? | ? | ? | ? |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ? | ? | ? | ? | ? | ? | ?
Disorder confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | . | . | . | . | . | . | . | . | . | 490 | . | . | . | . | . | . | . | . | . | 500 | . | . | . | . | . | . | . | . | . | 510 | . | . | . | . | . | . | . | . | . | 520 | . | . | . | . | . | . | . | . | . | 530 | . | . | . | . | . | . | . | . | . | 540
Sequence |  | I | E | A | F | N | E | T | I | K | I | F | E | E | Q | G | Q | T | Q | E | K | C | S | K | E | Y | L | E | R | F | R | R | E | G | N | E | K | E | M | Q | R | I | L | L | N | S | E | R | L | K | S | R | I | A | E | I | H | E | S | R | T
Secondary structure |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SS confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ? | ? | ? | ? |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ? | ? | ? | ? | ? |  |
Disorder confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | . | . | . | . | . | . | . | . | . | 550 | . | . | . | . | . | . | . | . | . | 560 | . | . | . | . | . | . | . | . | . | 570 | . | . | . | . | . | . | . | . | . | 580 | . | . | . | . | . | . | . | . | . | 590 | . | . | . | . | . | . | . | . | . | 600
Sequence |  | K | L | E | Q | Q | L | R | A | Q | A | S | D | N | R | E | I | D | K | R | M | N | S | L | K | P | D | L | M | Q | L | R | K | I | R | D | Q | Y | L | V | W | L | T | Q | K | G | A | R | Q | K | K | I | N | E | W | L | G | I | K | N | E
Secondary structure |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SS confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder |  |  |  |  |  |  |  |  |  |  |  |  | ? | ? | ? | ? | ? | ? | ? |  |  | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? |  |  | ? | ? | ? | ? | ? | ? |  | ? | ? | ? | ? | ? | ? | ? | ? |  |  |  | ? | ? | ? | ? |  | ? | ? | ? | ? | ?
Disorder confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | . | . | . | . | . | . | . | . | . | 610 | . | . | . | . | . | . | . | . | . | 620 | . | . | . | . | . | . | . | . | . | 630 | . | . | . | . | . | . | . | . | . | 640 | . | . | . | . | . | . | . | . | . | 650 | . | . | . | . | . | . | . | . | . | 660
Sequence |  | T | E | D | Q | Y | A | L | M | E | D | E | D | D | L | P | H | H | E | E | R | T | W | Y | V | G | K | I | N | R | T | Q | A | E | E | M | L | S | G | K | R | D | G | T | F | L | I | R | E | S | S | Q | R | G | C | Y | A | C | S | V | V
Secondary structure |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SS confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder |  | ? | ? | ? | ? | ? |  | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ? | ? | ? | ? | ? |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | . | . | . | . | . | . | . | . | . | 670 | . | . | . | . | . | . | . | . | . | 680 | . | . | . | . | . | . | . | . | . | 690 | . | . | . | . | . | . | . | . | . | 700 | . | . | . | . | . | . | . | . | . | 710 | . | . | . | . | . | . | . | . | . | 720
Sequence |  | V | D | G | D | T | K | H | C | V | I | Y | R | T | A | T | G | F | G | F | A | E | P | Y | N | L | Y | G | S | L | K | E | L | V | L | H | Y | Q | H | A | S | L | V | Q | H | N | D | A | L | T | V | T | L | A | H | P | V | R | A | P | G
Secondary structure |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SS confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ? | ? |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ? |
Disorder confidence |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | . | . | . | . | . | . | . | .
Sequence |  | P | G | P | P | P | A | A | R
Secondary structure |  |  |  |  |  |  |  |  |
SS confidence |  |  |  |  |  |  |  |  |
Disorder |  | ? | ? | ? | ? | ? | ? | ? | ?
Disorder confidence |  |  |  |  |  |  |  |  |

Confidence Key
High(9) |  |  |  |  |  |  |  |  |  |  | Low (0)

? | Disordered
| Alpha helix
| Beta strand

Domain analysis |

Hover over an aligned region to see model and summary info

Please note, only up to the top 20 hits are modelled to reduce computer load

Rank | Aligned region
--- | ---
1 |
| c2oq1A_ |

### PDB 2oq1 chain A

Region: 324 - 724
Aligned: 247
Modelled: 265
Confidence: 100.0%
Identity: 29%
PDB header:transferase
Chain: A: PDB Molecule:tyrosine-protein kinase zap-70;
PDBTitle: tandem sh2 domains of zap-70 with 19-mer zeta1 peptide

Phyre2
2 |
| c2ozoA_ |

### PDB 2ozo chain A

Region: 322 - 716
Aligned: 248
Modelled: 259
Confidence: 100.0%
Identity: 27%
PDB header:transferase
Chain: A: PDB Molecule:tyrosine-protein kinase zap-70;
PDBTitle: autoinhibited intact human zap-70

Phyre2
3 |
| c2y3aB_ |

### PDB 2y3a chain B

Region: 447 - 720
Aligned: 236
Modelled: 242
Confidence: 100.0%
Identity: 100%
PDB header:transferase
Chain: B: PDB Molecule:phosphatidylinositol 3-kinase regulatory subunit beta;
PDBTitle: crystal structure of p110beta in complex with icsh2 of p85beta and2 the drug gdc-0941

Phyre2
4 |
| c2b3oA_ |

### PDB 2b3o chain A

Region: 330 - 716
Aligned: 197
Modelled: 200
Confidence: 100.0%
Identity: 35%
PDB header:hydrolase
Chain: A: PDB Molecule:tyrosine-protein phosphatase, non-receptor type
PDBTitle: crystal structure of human tyrosine phosphatase shp-1

Phyre2
5 |
| c2shpA_ |

### PDB 2shp chain A

Region: 326 - 716
Aligned: 201
Modelled: 204
Confidence: 100.0%
Identity: 30%
PDB header:tyrosine phosphatase
Chain: A: PDB Molecule:shp-2;
PDBTitle: tyrosine phosphatase shp-2

Phyre2
6 |
| c1a81E_ |

### PDB 1a81 chain E

Region: 324 - 716
Aligned: 212
Modelled: 223
Confidence: 100.0%
Identity: 32%
PDB header:complex (transferase/peptide)
Chain: E: PDB Molecule:syk kinase;
PDBTitle: crystal structure of the tandem sh2 domain of the syk kinase bound to2 a dually tyrosine-phosphorylated itam

Phyre2
7 |
| c3ps5A_ |

### PDB 3ps5 chain A

Region: 330 - 719
Aligned: 200
Modelled: 203
Confidence: 100.0%
Identity: 29%
PDB header:hydrolase, signaling protein
Chain: A: PDB Molecule:tyrosine-protein phosphatase non-receptor type 6;
PDBTitle: crystal structure of the full-length human protein tyrosine2 phosphatase shp-1

Phyre2
8 |
| c1xa6A_ |

### PDB 1xa6 chain A

Region: 88 - 291
Aligned: 198
Modelled: 204
Confidence: 100.0%
Identity: 20%
PDB header:signaling protein
Chain: A: PDB Molecule:beta2-chimaerin;
PDBTitle: crystal structure of the human beta2-chimaerin

Phyre2
9 |
| c3gqiB_ |

### PDB 3gqi chain B

Region: 327 - 716
Aligned: 194
Modelled: 202
Confidence: 100.0%
Identity: 30%
PDB header:transferase/transferase inhibitor
Chain: B: PDB Molecule:phospholipase c-gamma-1;
PDBTitle: crystal structure of activated receptor tyrosine kinase in complex2 with substrates

Phyre2
10 |
| c3hizB_ |

### PDB 3hiz chain B

Region: 324 - 576
Aligned: 234
Modelled: 238
Confidence: 100.0%
Identity: 77%
PDB header:transferase/oncoprotein
Chain: B: PDB Molecule:phosphatidylinositol 3-kinase regulatory subunit
PDBTitle: crystal structure of p110alpha h1047r mutant in complex with2 nish2 of p85alpha

Phyre2
11 |
| c2ee5A_ |

### PDB 2ee5 chain A

Region: 86 - 298
Aligned: 205
Modelled: 213
Confidence: 100.0%
Identity: 20%
PDB header:hydrolase
Chain: A: PDB Molecule:rho gtpase activating protein 5 variant;
PDBTitle: solution structure of the n-teruminus extended rhogap2 domain from human rho gtpase activating protein 5 variant

Phyre2
12 |
| c2xs6A_ |

### PDB 2xs6 chain A

Region: 109 - 260
Aligned: 150
Modelled: 149
Confidence: 100.0%
Identity: 93%
PDB header:transferase
Chain: A: PDB Molecule:phosphatidylinositol 3-kinase regulatory subunit beta;
PDBTitle: crystal structure of the rhogap domain of human pik3r2

Phyre2
13 |
| c3byiA_ |

### PDB 3byi chain A

Region: 99 - 292
Aligned: 187
Modelled: 189
Confidence: 100.0%
Identity: 21%
PDB header:signaling protein
Chain: A: PDB Molecule:rho gtpase activating protein 15;
PDBTitle: crystal structure of human rho gtpase activating protein 15 (arhgap15)

Phyre2
14 |
| c2ngrB_ |

### PDB 2ngr chain B

Region: 102 - 291
Aligned: 184
Modelled: 190
Confidence: 100.0%
Identity: 21%
PDB header:hydrolase
Chain: B: PDB Molecule:protein (gtpase activating protein (rhg));
PDBTitle: transition state complex for gtp hydrolysis by cdc42:2 comparisons of the high resolution structures for cdc423 bound to the active and catalytically compromised forms of4 the cdc42-gap.

Phyre2
15 |
| c3qisA_ |

### PDB 3qis chain A

Region: 105 - 260
Aligned: 153
Modelled: 156
Confidence: 100.0%
Identity: 20%
PDB header:hydrolase/protein binding
Chain: A: PDB Molecule:inositol polyphosphate 5-phosphatase ocrl-1;
PDBTitle: recognition of the f&h motif by the lowe syndrome protein ocrl

Phyre2
16 |
| d1xa6a1 |

### PDB 1xa6 chain A domain 1

Region: 105 - 291
Aligned: 181
Modelled: 187
Confidence: 100.0%
Identity: 21%
Fold: GTPase activation domain, GAP
Superfamily: GTPase activation domain, GAP
Family: BCR-homology GTPase activation domain (BH-domain)

Phyre2
17 |
| d1tx4a_ |

### PDB 1tx4 chain A

Region: 103 - 291
Aligned: 183
Modelled: 189
Confidence: 100.0%
Identity: 21%
Fold: GTPase activation domain, GAP
Superfamily: GTPase activation domain, GAP
Family: BCR-homology GTPase activation domain (BH-domain)

Phyre2
18 |
| c3msxB_ |

### PDB 3msx chain B

Region: 104 - 291
Aligned: 181
Modelled: 184
Confidence: 100.0%
Identity: 15%
PDB header:protein binding
Chain: B: PDB Molecule:rho gtpase-activating protein 20;
PDBTitle: crystal structure of rhoa.gdp.mgf3 in complex with gap domain of2 arhgap20

Phyre2
19 |
| c3kuqA_ |

### PDB 3kuq chain A

Region: 103 - 288
Aligned: 176
Modelled: 186
Confidence: 100.0%
Identity: 15%
PDB header:hydrolase activator
Chain: A: PDB Molecule:rho gtpase-activating protein 7;
PDBTitle: crystal structure of the dlc1 rhogap domain

Phyre2
20 |
| c3iugA_ |

### PDB 3iug chain A

Region: 103 - 291
Aligned: 168
Modelled: 171
Confidence: 100.0%
Identity: 22%
PDB header:splicing
Chain: A: PDB Molecule:rho/cdc42/rac gtpase-activating protein rics;
PDBTitle: crystal structure of the rhogap domain of rics

Phyre2
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
31 |
32 |
33 |
34 |
35 |
36 |
37 |
38 |
39 |
40 |
41 |
42 |
43 |
44 |
45 |
46 |
47 |
48 |
49 |
50 |
51 |
52 |
53 |
54 |
55 |
56 |
57 |
58 |
59 |
60 |
61 |
62 |
63 |
64 |
65 |
66 |
67 |
68 |
69 |
70 |
71 |
72 |
73 |
74 |
75 |
76 |
77 |
78 |
79 |
80 |
81 |
82 |
83 |
84 |
85 |
86 |
87 |
88 |
89 |
90 |
91 |
92 |
93 |
94 |
95 |
96 |
97 |
98 |
99 |
100 |
101 |
102 |
103 |
104 |
105 |
106 |
107 |
108 |
109 |
110 |
111 |
112 |
113 |
114 |
115 |
116 |
117 |
118 |
119 |
| c2kt1A_ |

### PDB 2kt1 chain A

Region: 1 - 80
Aligned: 80
Modelled: 80
Confidence: 99.4%
Identity: 100%
PDB header:protein binding
Chain: A: PDB Molecule:phosphatidylinositol 3-kinase regulatory subunit
PDBTitle: solution nmr structure of the sh3 domain from the p85beta2 subunit of phosphatidylinositol 3-kinase from h.sapiens,3 northeast structural genomics consortium target hr5531e

Phyre2
120 |
121 |
122 |
123 |
124 |
125 |
126 |
127 |
128 |
129 |
130 |
131 |
132 |
133 |
134 |
135 |
136 |
137 |
138 |
139 |
140 |
141 |
142 |
143 |
144 |
145 |
146 |
147 |
148 |
149 |
150 |
151 |
152 |
153 |
154 |
155 |
156 |
157 |
158 |
159 |
160 |
161 |
162 |
163 |
164 |
165 |
166 |
167 |
168 |
169 |
170 |
171 |
172 |
173 |
174 |
175 |
176 |
177 |
178 |
179 |
180 |
181 |
182 |
183 |
184 |
185 |
186 |
187 |
188 |
189 |
190 |
191 |
192 |
193 |
194 |
195 |
196 |
197 |
198 |
199 |
200 |
201 |
202 |
203 |
204 |
205 |
206 |
207 |
208 |
209 |
210 |
211 |
212 |
213 |
214 |
215 |
216 |
217 |
218 |
219 |
220 |
221 |
222 |
223 |
224 |
225 |
226 |
227 |
228 |
229 |
230 |
231 |
232 |
233 |
234 |
235 |
236 |
237 |
238 |
239 |
240 |
241 |
242 |
243 |
244 |
245 |
246 |
247 |
248 |
249 |
250 |
251 |
252 |
253 |
254 |
255 |
256 |
257 |
258 |
259 |
260 |
261 |
262 |
263 |
264 |
265 |
266 |
267 |
268 |
269 |
270 |
271 |
272 |
273 |
274 |
275 |
276 |
277 |
278 |
279 |
280 |
281 |
282 |
283 |
284 |
285 |
286 |
287 |
288 |
289 |
290 |
291 |
292 |
293 |
294 |
295 |
296 |
297 |
298 |
299 |
300 |
301 |
302 |
303 |
304 |
305 |
306 |
307 |
308 |
309 |
310 |
311 |
312 |
313 |
314 |
315 |
316 |
317 |
318 |
319 |
320 |
321 |
322 |
323 |
324 |
325 |
326 |
327 |
328 |
329 |
330 |
331 |
332 |
333 |
334 |
335 |
336 |
337 |
338 |
339 |
340 |
341 |
342 |
343 |
344 |
345 |
346 |
347 |
348 |
349 |
350 |
351 |
352 |
353 |
354 |
355 |
356 |
357 |
358 |
359 |
360 |
361 |
362 |
363 |
364 |
365 |
366 |
367 |
368 |
369 |
370 |
371 |
372 |
373 |
374 |
375 |
376 |
377 |
378 |
379 |
380 |
381 |
382 |
383 |
384 |
385 |
386 |
387 |
388 |
389 |
390 |
391 |
392 |
393 |
394 |
395 |
396 |
397 |
398 |
399 |
400 |
401 |
402 |
403 |
404 |
405 |
406 |
407 |
408 |
409 |
410 |
411 |
412 |
413 |
414 |
415 |
416 |
417 |
418 |
419 |

Detailed template information |

# | Template | Alignment Coverage | 3D Model | Confidence | % i.d. | Template Information
--- | --- | --- | --- | --- | --- | ---
1 | c2oq1A_ |
|  | 100.0 | 29 | PDB header:transferase Chain: A: PDB Molecule:tyrosine-protein kinase zap-70; PDBTitle: tandem sh2 domains of zap-70 with 19-mer zeta1 peptide
2 | c2ozoA_ |
|  | 100.0 | 27 | PDB header:transferase Chain: A: PDB Molecule:tyrosine-protein kinase zap-70; PDBTitle: autoinhibited intact human zap-70
3 | c2y3aB_ |
|  | 100.0 | 100 | PDB header:transferase Chain: B: PDB Molecule:phosphatidylinositol 3-kinase regulatory subunit beta; PDBTitle: crystal structure of p110beta in complex with icsh2 of p85beta and2 the drug gdc-0941
4 | c2b3oA_ |
|  | 100.0 | 35 | PDB header:hydrolase Chain: A: PDB Molecule:tyrosine-protein phosphatase, non-receptor type PDBTitle: crystal structure of human tyrosine phosphatase shp-1
5 | c2shpA_ |
|  | 100.0 | 30 | PDB header:tyrosine phosphatase Chain: A: PDB Molecule:shp-2; PDBTitle: tyrosine phosphatase shp-2
6 | c1a81E_ |
|  | 100.0 | 32 | PDB header:complex (transferase/peptide) Chain: E: PDB Molecule:syk kinase; PDBTitle: crystal structure of the tandem sh2 domain of the syk kinase bound to2 a dually tyrosine-phosphorylated itam
7 | c3ps5A_ |
|  | 100.0 | 29 | PDB header:hydrolase, signaling protein Chain: A: PDB Molecule:tyrosine-protein phosphatase non-receptor type 6; PDBTitle: crystal structure of the full-length human protein tyrosine2 phosphatase shp-1
8 | c1xa6A_ |
|  | 100.0 | 20 | PDB header:signaling protein Chain: A: PDB Molecule:beta2-chimaerin; PDBTitle: crystal structure of the human beta2-chimaerin
9 | c3gqiB_ |
|  | 100.0 | 30 | PDB header:transferase/transferase inhibitor Chain: B: PDB Molecule:phospholipase c-gamma-1; PDBTitle: crystal structure of activated receptor tyrosine kinase in complex2 with substrates
10 | c3hizB_ |
|  | 100.0 | 77 | PDB header:transferase/oncoprotein Chain: B: PDB Molecule:phosphatidylinositol 3-kinase regulatory subunit PDBTitle: crystal structure of p110alpha h1047r mutant in complex with2 nish2 of p85alpha
11 | c2ee5A_ |
|  | 100.0 | 20 | PDB header:hydrolase Chain: A: PDB Molecule:rho gtpase activating protein 5 variant; PDBTitle: solution structure of the n-teruminus extended rhogap2 domain from human rho gtpase activating protein 5 variant
12 | c2xs6A_ |
|  | 100.0 | 93 | PDB header:transferase Chain: A: PDB Molecule:phosphatidylinositol 3-kinase regulatory subunit beta; PDBTitle: crystal structure of the rhogap domain of human pik3r2
13 | c3byiA_ |
|  | 100.0 | 21 | PDB header:signaling protein Chain: A: PDB Molecule:rho gtpase activating protein 15; PDBTitle: crystal structure of human rho gtpase activating protein 15 (arhgap15)
14 | c2ngrB_ |
|  | 100.0 | 21 | PDB header:hydrolase Chain: B: PDB Molecule:protein (gtpase activating protein (rhg)); PDBTitle: transition state complex for gtp hydrolysis by cdc42:2 comparisons of the high resolution structures for cdc423 bound to the active and catalytically compromised forms of4 the cdc42-gap.
15 | c3qisA_ |
|  | 100.0 | 20 | PDB header:hydrolase/protein binding Chain: A: PDB Molecule:inositol polyphosphate 5-phosphatase ocrl-1; PDBTitle: recognition of the f&h motif by the lowe syndrome protein ocrl
16 | d1xa6a1 |
|  | 100.0 | 21 | Fold:GTPase activation domain, GAP Superfamily:GTPase activation domain, GAP Family:BCR-homology GTPase activation domain (BH-domain)
17 | d1tx4a_ |
|  | 100.0 | 21 | Fold:GTPase activation domain, GAP Superfamily:GTPase activation domain, GAP Family:BCR-homology GTPase activation domain (BH-domain)
18 | c3msxB_ |
|  | 100.0 | 15 | PDB header:protein binding Chain: B: PDB Molecule:rho gtpase-activating protein 20; PDBTitle: crystal structure of rhoa.gdp.mgf3 in complex with gap domain of2 arhgap20
19 | c3kuqA_ |
|  | 100.0 | 15 | PDB header:hydrolase activator Chain: A: PDB Molecule:rho gtpase-activating protein 7; PDBTitle: crystal structure of the dlc1 rhogap domain
20 | c3iugA_ |
|  | 100.0 | 22 | PDB header:splicing Chain: A: PDB Molecule:rho/cdc42/rac gtpase-activating protein rics; PDBTitle: crystal structure of the rhogap domain of rics
21 | d1pbwa_ |
| not modelled | 100.0 | 35 | Fold:GTPase activation domain, GAP Superfamily:GTPase activation domain, GAP Family:BCR-homology GTPase activation domain (BH-domain)
22 | c3fk2B_ |
| not modelled | 100.0 | 19 | PDB header:signaling protein, hydrolase activator Chain: B: PDB Molecule:glucocorticoid receptor dna-binding factor 1; PDBTitle: crystal structure of the rhogap domain of human2 glucocorticoid receptor dna-binding factor 1
23 | c1pbwB_ |
| not modelled | 100.0 | 35 | PDB header:phosphotransferase Chain: B: PDB Molecule:phosphatidylinositol 3-kinase; PDBTitle: structure of bcr-homology (bh) domain
24 | d1f7ca_ |
| not modelled | 100.0 | 23 | Fold:GTPase activation domain, GAP Superfamily:GTPase activation domain, GAP Family:BCR-homology GTPase activation domain (BH-domain)
25 | c1f7cA_ |
| not modelled | 100.0 | 23 | PDB header:signaling protein Chain: A: PDB Molecule:rhogap protein; PDBTitle: crystal structure of the bh domain from graf, the gtpase2 regulator associated with focal adhesion kinase
26 | c2ovjA_ |
| not modelled | 100.0 | 27 | PDB header:signaling protein Chain: A: PDB Molecule:rac gtpase-activating protein 1; PDBTitle: the crystal structure of the human rac gtpase activating protein 12 (racgap1) mgcracgap.
27 | c2qv2A_ |
| not modelled | 100.0 | 22 | PDB header:hydrolase Chain: A: PDB Molecule:inositol polyphosphate 5-phosphatase ocrl-1; PDBTitle: a role of the lowe syndrome protein ocrl in early steps of2 the endocytic pathway
28 | c3eapD_ |
| not modelled | 99.9 | 20 | PDB header:hydrolase activator Chain: D: PDB Molecule:rho gtpase-activating protein 11a; PDBTitle: crystal structure of the rhogap domain of arhgap11a
29 | d2oq1a1 |
| not modelled | 99.9 | 29 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
30 | d1pica_ |
| not modelled | 99.9 | 73 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
31 | d1qada_ |
| not modelled | 99.9 | 79 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
32 | d1a81a1 |
| not modelled | 99.9 | 28 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
33 | c2dlyA_ |
| not modelled | 99.9 | 35 | PDB header:transferase Chain: A: PDB Molecule:fyn-related kinase; PDBTitle: solution structure of the sh2 domain of murine fyn-related2 kinase
34 | d2oq1a2 |
| not modelled | 99.9 | 28 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
35 | c2crhA_ |
| not modelled | 99.9 | 28 | PDB header:signaling protein Chain: A: PDB Molecule:vav proto-oncogene; PDBTitle: solution structure of the sh2 domain of human proto-2 oncogene protein vav1
36 | d1a81e1 |
| not modelled | 99.9 | 28 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
37 | d1a81a2 |
| not modelled | 99.9 | 34 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
38 | c2dlzA_ |
| not modelled | 99.9 | 26 | PDB header:signaling protein Chain: A: PDB Molecule:protein vav-2; PDBTitle: solution structure of the sh2 domain of human protein vav-2
39 | d1a81e2 |
| not modelled | 99.9 | 33 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
40 | c2eo6A_ |
| not modelled | 99.9 | 29 | PDB header:signaling protein Chain: A: PDB Molecule:b-cell linker protein; PDBTitle: solution structure of the sh2 domain from mouse b-cell2 linker protein blnk
41 | c2fo0A_ |
| not modelled | 99.9 | 29 | PDB header:transferase Chain: A: PDB Molecule:proto-oncogene tyrosine-protein kinase abl1 (1b isoform); PDBTitle: organization of the sh3-sh2 unit in active and inactive forms of the2 c-abl tyrosine kinase
42 | c2ablA_ |
| not modelled | 99.9 | 34 | PDB header:transferase Chain: A: PDB Molecule:abl tyrosine kinase; PDBTitle: sh3-sh2 domain fragment of human bcr-abl tyrosine kinase
43 | c2lctA_ |
| not modelled | 99.9 | 29 | PDB header:signaling protein Chain: A: PDB Molecule:proto-oncogene vav; PDBTitle: solution structure of the vav1 sh2 domain complexed with a syk-derived2 doubly phosphorylated peptide
44 | c2ge9A_ |
| not modelled | 99.9 | 29 | PDB header:transferase Chain: A: PDB Molecule:tyrosine-protein kinase btk; PDBTitle: solution structures of the sh2 domain of bruton's tyrosine2 kinase
45 | c2eobA_ |
| not modelled | 99.9 | 31 | PDB header:hydrolase Chain: A: PDB Molecule:1-phosphatidylinositol-4,5-bisphosphate PDBTitle: solution structure of the second sh2 domain from rat plc2 gamma-2
46 | c1oplA_ |
| not modelled | 99.9 | 28 | PDB header:transferase Chain: A: PDB Molecule:proto-oncogene tyrosine-protein kinase; PDBTitle: structural basis for the auto-inhibition of c-abl tyrosine2 kinase
47 | d1csya_ |
| not modelled | 99.9 | 31 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
48 | c2gsbA_ |
| not modelled | 99.9 | 23 | PDB header:signaling protein Chain: A: PDB Molecule:ras gtpase-activating protein 1; PDBTitle: solution structure of the second sh2 domain of human ras2 gtpase-activating protein 1
49 | d1opka2 |
| not modelled | 99.9 | 32 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
50 | d1lkka_ |
| not modelled | 99.9 | 37 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
51 | d1qcfa2 |
| not modelled | 99.9 | 37 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
52 | d2shpa2 |
| not modelled | 99.9 | 27 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
53 | d1jwoa_ |
| not modelled | 99.8 | 27 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
54 | d1nrva_ |
| not modelled | 99.8 | 24 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
55 | d1k9aa2 |
| not modelled | 99.8 | 33 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
56 | c2ysxA_ |
| not modelled | 99.8 | 29 | PDB header:signaling protein Chain: A: PDB Molecule:signaling inositol polyphosphate phosphatase PDBTitle: solution structure of the human ship sh2 domain
57 | c1y57A_ |
| not modelled | 99.8 | 31 | PDB header:transferase Chain: A: PDB Molecule:proto-oncogene tyrosine-protein kinase src; PDBTitle: structure of unphosphorylated c-src in complex with an inhibitor
58 | c2knoA_ |
| not modelled | 99.8 | 32 | PDB header:hydrolase Chain: A: PDB Molecule:tensin-like c1 domain-containing phosphatase; PDBTitle: nmr solution structure of sh2 domain of the human tensin like c12 domain containing phosphatase (tenc1)
59 | d1o48a_ |
| not modelled | 99.8 | 34 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
60 | d1rjaa_ |
| not modelled | 99.8 | 33 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
61 | c2lqnA_ |
| not modelled | 99.8 | 26 | PDB header:signaling protein Chain: A: PDB Molecule:crk-like protein; PDBTitle: solution structure of crkl
62 | c1k9aB_ |
| not modelled | 99.8 | 29 | PDB header:transferase Chain: B: PDB Molecule:carboxyl-terminal src kinase; PDBTitle: crystal structure analysis of full-length carboxyl-terminal2 src kinase at 2.5 a resolution
63 | d1bkla_ |
| not modelled | 99.8 | 34 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
64 | c1ka6A_ |
| not modelled | 99.8 | 29 | PDB header:immune system Chain: A: PDB Molecule:sh2 domain protein 1a; PDBTitle: sap/sh2d1a bound to peptide n-py
65 | d1luia_ |
| not modelled | 99.8 | 28 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
66 | d1blja_ |
| not modelled | 99.8 | 32 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
67 | d2qmsa1 |
| not modelled | 99.8 | 27 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
68 | c3nhnA_ |
| not modelled | 99.8 | 36 | PDB header:transferase Chain: A: PDB Molecule:tyrosine-protein kinase hck; PDBTitle: crystal structure of the src-family kinase hck sh3-sh2-linker2 regulatory region
69 | d1fhsa_ |
| not modelled | 99.8 | 33 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
70 | d1g83a2 |
| not modelled | 99.8 | 34 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
71 | c2eo3A_ |
| not modelled | 99.8 | 30 | PDB header:signaling protein Chain: A: PDB Molecule:crk-like protein; PDBTitle: solution structure of the sh2 domain from human crk-like2 protein
72 | d1f2fa_ |
| not modelled | 99.8 | 34 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
73 | d1ayaa_ |
| not modelled | 99.8 | 28 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
74 | c1x27F_ |
| not modelled | 99.8 | 34 | PDB header:signaling protein Chain: F: PDB Molecule:proto-oncogene tyrosine-protein kinase lck; PDBTitle: crystal structure of lck sh2-sh3 with sh2 binding site of2 p130cas
75 | d1i3za_ |
| not modelled | 99.8 | 32 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
76 | c2dm0A_ |
| not modelled | 99.8 | 29 | PDB header:transferase Chain: A: PDB Molecule:tyrosine-protein kinase txk; PDBTitle: solution structure of the sh2 domain of human tyrosine-2 protein kinase txk
77 | d1d4ta_ |
| not modelled | 99.8 | 29 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
78 | c1x6cA_ |
| not modelled | 99.8 | 28 | PDB header:signaling protein Chain: A: PDB Molecule:tyrosine-protein phosphatase, non-receptor type PDBTitle: solution structures of the sh2 domain of human protein-2 tyrosine phosphatase shp-1
79 | c2vifA_ |
| not modelled | 99.8 | 35 | PDB header:signaling protein Chain: A: PDB Molecule:suppressor of cytokine signalling 6; PDBTitle: crystal structure of socs6 sh2 domain in complex with a c-kit2 phosphopeptide
80 | d2izva2 |
| not modelled | 99.8 | 26 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
81 | d3c7ia1 |
| not modelled | 99.8 | 35 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
82 | c2ekxA_ |
| not modelled | 99.8 | 32 | PDB header:signaling protein Chain: A: PDB Molecule:cytoplasmic tyrosine-protein kinase bmx; PDBTitle: solution structure of the human bmx sh2 domain
83 | d2cs0a1 |
| not modelled | 99.8 | 27 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
84 | c2h8hA_ |
| not modelled | 99.8 | 30 | PDB header:transferase Chain: A: PDB Molecule:proto-oncogene tyrosine-protein kinase src; PDBTitle: src kinase in complex with a quinazoline inhibitor
85 | c2c0iA_ |
| not modelled | 99.8 | 34 | PDB header:transferase Chain: A: PDB Molecule:tyrosine-protein kinase hck; PDBTitle: src family kinase hck with bound inhibitor a-420983
86 | c2hmhA_ |
| not modelled | 99.8 | 26 | PDB header:cytokine regulator Chain: A: PDB Molecule:suppressor of cytokine signaling 3; PDBTitle: crystal structure of socs3 in complex with gp130(ptyr757)2 phosphopeptide.
87 | d1cwea_ |
| not modelled | 99.8 | 40 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
88 | d1fu6a_ |
| not modelled | 99.8 | 32 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
89 | d2eyva1 |
| not modelled | 99.8 | 33 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
90 | d2shpa3 |
| not modelled | 99.8 | 29 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
91 | d2fcia1 |
| not modelled | 99.8 | 28 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
92 | c2dcrA_ |
| not modelled | 99.8 | 26 | PDB header:transferase Chain: A: PDB Molecule:proto-oncogene tyrosine-protein kinase fes/fps; PDBTitle: fully automated solution structure determination of the fes2 sh2 domain
93 | c3mazA_ |
| not modelled | 99.8 | 17 | PDB header:signaling protein Chain: A: PDB Molecule:signal-transducing adaptor protein 1; PDBTitle: crystal structure of the human brdg1/stap-1 sh2 domain in complex with2 the ntal ptyr136 peptide
94 | d1r1qa_ |
| not modelled | 99.8 | 33 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
95 | c1g83A_ |
| not modelled | 99.8 | 35 | PDB header:transferase Chain: A: PDB Molecule:proto-oncogene tyrosine-protein kinase fyn; PDBTitle: crystal structure of fyn sh3-sh2
96 | c2c9wA_ |
| not modelled | 99.8 | 27 | PDB header:transcription regulation Chain: A: PDB Molecule:suppressor of cytokine signaling 2; PDBTitle: crystal structure of socs-2 in complex with elongin-b and2 elongin-c at 1.9a resolution
97 | c2ci8A_ |
| not modelled | 99.8 | 29 | PDB header:translation Chain: A: PDB Molecule:cytoplasmic protein nck1; PDBTitle: sh2 domain of human nck1 adaptor protein - uncomplexed
98 | d1jyra_ |
| not modelled | 99.8 | 37 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
99 | c3or8A_ |
| not modelled | 99.8 | 29 | PDB header:transcription Chain: A: PDB Molecule:transcription elongation factor spt6; PDBTitle: a tandem sh2 domain in transcription elongation factor spt6
100 | c2izvA_ |
| not modelled | 99.8 | 24 | PDB header:transcription Chain: A: PDB Molecule:suppressor of cytokine signaling 4; PDBTitle: crystal structure of socs-4 in complex with elongin-b and2 elongin-c at 2.55a resolution
101 | d1mila_ |
| not modelled | 99.7 | 25 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
102 | c2el8A_ |
| not modelled | 99.7 | 18 | PDB header:signaling protein Chain: A: PDB Molecule:signal-transducing adaptor protein 2; PDBTitle: solution structure of the human stap2 sh2 domain
103 | c2kk6A_ |
| not modelled | 99.7 | 30 | PDB header:transferase Chain: A: PDB Molecule:proto-oncogene tyrosine-protein kinase fer; PDBTitle: solution structure of sh2 domain of proto-oncogene tyrosine-2 protein kinase fer from homo sapiens, northeast structural3 genomics consortium (nesg) target hr3461d
104 | d2c9wa2 |
| not modelled | 99.7 | 25 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
105 | c2cr4A_ |
| not modelled | 99.7 | 24 | PDB header:signaling protein Chain: A: PDB Molecule:sh3 domain-binding protein 2; PDBTitle: solution structure of the sh2 domain of human sh3bp2 protein
106 | d1xa6a2 |
| not modelled | 99.7 | 20 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
107 | c2dx0B_ |
| not modelled | 99.7 | 36 | PDB header:hydrolase Chain: B: PDB Molecule:phospholipase c, gamma 2; PDBTitle: crystal structure of the n-terminal sh2 domain of mouse2 phospholipase c-gamma 2
108 | c3gxxB_ |
| not modelled | 99.7 | 25 | PDB header:transcription Chain: B: PDB Molecule:transcription elongation factor spt6; PDBTitle: structure of the sh2 domain of the candida glabrata2 transcription elongation factor spt6, crystal form b
109 | d1rpya_ |
| not modelled | 99.7 | 20 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
110 | c2xp1A_ |
| not modelled | 99.7 | 18 | PDB header:transcription Chain: A: PDB Molecule:spt6; PDBTitle: structure of the tandem sh2 domains from antonospora locustae2 transcription elongation factor spt6
111 | c1rqqC_ |
| not modelled | 99.7 | 22 | PDB header:transferase/signaling protein Chain: C: PDB Molecule:adaptor protein aps; PDBTitle: crystal structure of the insulin receptor kinase in complex2 with the sh2 domain of aps
112 | c2eyzA_ |
| not modelled | 99.7 | 30 | PDB header:signaling protein Chain: A: PDB Molecule:v-crk sarcoma virus ct10 oncogene homolog PDBTitle: ct10-regulated kinase isoform ii
113 | c3qwxX_ |
| not modelled | 99.7 | 25 | PDB header:signaling protein Chain: X: PDB Molecule:cell death abnormality protein 2; PDBTitle: ced-2 1-174
114 | c2dvjA_ |
| not modelled | 99.7 | 36 | PDB header:signaling protein Chain: A: PDB Molecule:v-crk sarcoma virus ct10 oncogene homolog, PDBTitle: phosphorylated crk-ii
115 | c2eyyA_ |
| not modelled | 99.7 | 29 | PDB header:signaling protein Chain: A: PDB Molecule:v-crk sarcoma virus ct10 oncogene homolog PDBTitle: ct10-regulated kinase isoform i
116 | c3qwyA_ |
| not modelled | 99.6 | 25 | PDB header:signaling protein Chain: A: PDB Molecule:cell death abnormality protein 2; PDBTitle: ced-2
117 | c2v1yB_ |
| not modelled | 99.5 | 73 | PDB header:transferase Chain: B: PDB Molecule:phosphatidylinositol 3-kinase regulatory subunit alpha; PDBTitle: structure of a phosphoinositide 3-kinase alpha adaptor-2 binding domain (abd) in a complex with the ish2 domain3 from p85 alpha
118 | d1uura3 |
| not modelled | 99.4 | 18 | Fold:SH2-like Superfamily:SH2 domain Family:SH2 domain
119 | c2kt1A_ |
|  | 99.4 | 100 | PDB header:protein binding Chain: A: PDB Molecule:phosphatidylinositol 3-kinase regulatory subunit PDBTitle: solution nmr structure of the sh3 domain from the p85beta2 subunit of phosphatidylinositol 3-kinase from h.sapiens,3 northeast structural genomics consortium target hr5531e
120 | d1phta_ |
| not modelled | 99.3 | 51 | Fold:SH3-like barrel Superfamily:SH3-domain Family:SH3-domain

Binding site prediction |

Due to computational demand, binding site predictions are not run for batch jobs

If you want to predict binding sites, please manually submit your model of choice to 3DLigandSite

Transmembrane helix prediction |

Transmembrane helices have been predicted in your sequence to adopt the topology shown below